Managing Chronic Tendon Pain by Metformin
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- James Wang
- Study ID
- NCT06100822
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Achilles Tendinopathy
- Chronic Pain
- Tendinopathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Metformin — DRUG500 mg capsules of Metformin Extended Release
- Placebo — DRUG500 mg capsules of placebo pills
Study Details
The purpose of the current exploratory clinical trial is to determine the effect of oral ingestion of metformin (OIM) in non-diabetic patients with chronic Achilles tendon pain. The trial has two aims; 1) to assess the effects of OIM treatment on tendon pain, and 2) to determine the effects of OIM capsules on tendon healing and repair. Twenty participants will be treated with metformin capsules for 16 weeks combined with a home exercise program. A comparison group of 20 participants will be treated with placebo tablets along with home exercise program.
Key Dates
- Start date
- May 24, 2024
- Status verified
- Nov 2025
- Primary completion
- Aug 31, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placebo Group, Placebo CapsulesPlacebo Group (n=20) Week 1: One placebo capsule (500 mg) daily Week 2: Two placebo capsules (1,000 mg) daily Week 3: Three placebo capsules (1,500 mg) daily Week 4-16: Four placebo capsules (2,000 mg) daily
- Experimental: Treatment Group, Metformin CapsulesTreatment Group (n=20) Week 1: One metformin ER capsule (500 mg) daily Week 2: Two metformin (ER) capsules (1,000 mg) daily Week 3: Three metformin (ER) capsules (1,500 mg) daily Week 4-16: Four metformin (ER) capsules (2,000 mg) daily
Primary Outcome Measure
Change in Victorian Institute of Sport Assessment - Achilles (VISA-A) Score [ Time Frame: baseline, 4 weeks, 16 weeks ]
Central Contacts
- James H Wang, PhD4126489102
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | Jessica Eldridge |
Find similar trials in Pittsburgh, PA
By research site
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory TestingRecruiting · Anna Evans Phillips · Baltimore, Maryland
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic PancreatitisRecruiting · University of Pittsburgh · Indianapolis, Indiana